Top Pharma Companies in India by Market Cap

BSE Sensex 74682.53 176.46 (-0.24%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Take Ltd.	Q V PT	238 Small Cap	16.20 (-1.70%)	19.01	7.6	-100.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Suven Life Sciences Ltd.	Q V+ PT	9,679 Small Cap	339 (0.24%)	N/A	17.16	-12.01	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Aster DM Quality Care Ltd.	Q V+ PT	65,885 Mid Cap	756.40 (-0.01%)	206.91	15.59	-11.61	19.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Aurobindo Pharma Ltd.	Q V+ PT	99,828 Mid Cap	1,701.70 (-0.90%)	38.11	4.21	-6.73	-4.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Ind-Swift Laboratories Ltd.	Q V+ PT	3,245 Small Cap	406.75 (6.60%)	57.88	2.22	-6.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Solara Active Pharma Sciences Ltd.	Q V PT	3,574 Small Cap	751.40 (-0.69%)	N/A	2.87	-3.27	-145.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Hikal Ltd.	Q V+ PT	2,788 Small Cap	229.65 (0.22%)	N/A	2.37	-0.09	-53.23	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Fabtech Technologies Ltd.	Q V PT	659 Small Cap	147.85 (0.00%)	13.5	1.55	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	9,249 Small Cap	3,975 (-0.72%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Tarsons Products Ltd.	Q V PT	1,631 Small Cap	334.30 (-1.68%)	163.05	2.86	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Laxmi Dental Ltd.	Q V PT	1,087 Small Cap	193.40 (-0.67%)	34.69	4.24	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Novartis India Ltd.	Q V+ PT	5,080 Small Cap	2,005.30 (0.13%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	5,957 Small Cap	202.85 (-0.15%)	35.47	3.2	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	KMC Speciality Hospitals (India) Ltd.	Q V+ PT	2,453 Small Cap	163.40 (1.84%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Sanofi India Ltd.	Q V PT	7,112 Small Cap	3,072.60 (-0.16%)	17.15	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,598 Small Cap	5,339.95 (1.41%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Gujarat Themis Biosyn Ltd.	Q V PT	5,566 Small Cap	415.45 (0.25%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Sai Parenterals Ltd.	Q V PT	2,257 Small Cap	507.90 (-0.63%)	136.82	2.89	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	CORONA Remedies Ltd.	Q V+ PT	13,448 Small Cap	2,193 (-0.96%)	68.04	16.78	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Anlon Healthcare Ltd.	Q V+ PT	1,219 Small Cap	29.04 (10.00%)	49.21	4.81	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Park Medi World Ltd.	Q V PT	12,187 Small Cap	281.65 (-1.05%)	47.63	5.86	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Medico Remedies Ltd.	Q V PT	291 Small Cap	34.26 (0.47%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Senores Pharmaceuticals Ltd.	Q V+ PT	6,474 Small Cap	1,384 (-0.50%)	50.69	6.65	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Aarti Pharmalabs Ltd.	Q V+ PT	7,443 Small Cap	901 (6.44%)	36.88	3.74	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Procter & Gamble Health Ltd.	Q V PT	9,133 Small Cap	5,470 (-0.66%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Onesource Specialty Pharma Ltd.	Q V PT	18,295 Small Cap	1,596.55 (-0.22%)	N/A	3.14	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Supriya Lifescience Ltd.	Q V+ PT	7,288 Small Cap	950.10 (-0.82%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Indraprastha Medical Corporation Ltd.	Q V PT	3,326 Small Cap	365.55 (-0.44%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Bajaj Healthcare Ltd.	Q V PT	1,108 Small Cap	338.75 (0.82%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Shukra Pharmaceuticals Ltd.	Q V+ PT	2,467 Small Cap	57.35 (3.82%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	29.04	10%
Ind-Swift Labs.	406.75	6.60%
Aarti Pharmalabs	901	6.44%
Syncom Formulations	20.81	5.10%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Kopran	272.95	-3.57%
Kwality Pharma	3,700	-3.57%
Guj. Kidney & Super	176.90	-3.41%
Acutaas Chemicals	3,314.50	-3.15%
Concord Biotech	1,545	-2.26%

News about Top Pharma Companies in India

Sep, 2026

Park Medi World informs about press release

Pursuant to Regulation 30 of the Listing Regulations, Park Medi World has informed that it enclosed Press Release titled ‘Park Group of Hospitals Wins Three Honours at Healthcare Pioneers of Delhi 2026’. The above disclosure is also being made available on the website of the Company at https://www.parkhospital.in/.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Anlon Healthcare incorporates subsidiary in Nigeria

This subsidiary will provide access to 16 Western African Countries via its local entity

Sep, 2026

Anlon Healthcare informs about incorporation of subsidiary

Pursuant to regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (‘SEBI Master Circular’), Anlon Healthcare has informed that ‘ANLON HEALTHCARE NIGERIA’ having Registration Number ‘9874492’ has been incorporated as a subsidiary of the Company, with effect from September 20, 2026. The relevant details pursuant to Schedule III of the Listing Regulations and additional details as required under the SEBI Master Circular for compliance with the provisions of the Listing Regulations by listed entities is annexed in Annexure - A.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Corona Remedies informs about analyst meet

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Corona Remedies has informed that the officials of the Company will be meeting analysts / investors on Wednesday, September 23, 2026 at 2:00 pm organized by JP Morgan in Ahmedabad. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This intimation is also being made available on the website of the Company at www.coronaremedies.com.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Gujarat Themis Biosyn informs about acquisition

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations;), Gujarat Themis Biosyn has informed that the company (GTBL) has completed the acquisition of MicroBiopharm Japan Co., (MBJ), Japan, through its wholly owned subsidiary, Themis Biosyn Japan (TBJ), by making an investment of INR 475 Crores towards capital contribution and INR 745 Crores by way of loan in TBJ. In this regard GTBL has entered into a Loan agreement with TBJ for an amount upto INR 800 Crores on the terms as may be agreed. Details of the agreement are given in annexure 1 attached. A Press release in this respect is attached.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Fabtech Technologies surges on bagging Rs 21 crore turnkey project

The order marks the company’s entry into this CIS market and expands the company’s international execution footprint into a technically demanding geography

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Take Ltd.	238 Crore
2	Suven Life Sciences Ltd.	9,679 Crore
3	Aster DM Quality Care Ltd.	65,885 Crore
4	Aurobindo Pharma Ltd.	99,828 Crore
5	Ind-Swift Laboratories Ltd.	3,245 Crore
6	Solara Active Pharma Sciences Ltd.	3,574 Crore
7	Hikal Ltd.	2,788 Crore
8	Fabtech Technologies Ltd.	659 Crore
9	Sanofi Consumer Healthcare India Ltd.	9,249 Crore
10	Tarsons Products Ltd.	1,631 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,170	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,950	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,461	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,126	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,505	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,023	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,607	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,702	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,414	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,935	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,607	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,463	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,505	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,171	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,935	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,607	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,126	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,461	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,170	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,215	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Park Medi World informs about press release

Anlon Healthcare incorporates subsidiary in Nigeria

Anlon Healthcare informs about incorporation of subsidiary

Corona Remedies informs about analyst meet

Gujarat Themis Biosyn informs about acquisition

Fabtech Technologies surges on bagging Rs 21 crore turnkey project

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?